Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer;El estado nutricional, la inflamación sistémica y el pronóstico de los pacientes con cáncer gastrointestinal

Nutricion Hospitalaria

Volumn 27, Issue 3, 2012, Pages 707-714

  Gomes de Lima, K V ^a   Maio, R ^b  

^a Barao de Lucena Hospital   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

C reactive protein; Cancer; Gastrointestinal tract; Inflammation; Malnutrition

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; INFLAMMATION; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INFLAMMATION; MALE; MALNUTRITION; MIDDLE AGED; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PROGNOSIS;

EID: 84861779265     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2012.27.3.5567     Document Type: Article

References (35)

1. Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2010: Incidência de câncer no Brasil. Instituto Nacional de Câncer. Rio de Janeiro: INCA, 2009. [serial on line] [21 jan 2010] Avaiable from: http://www.inca.gov.br
2. Béliveau R, Gingras D. Role of nutrition in preventing cancer. Can Fam Physician 2007; 53 (11): 1905-1911.
3. Garófolos A et al. Dieta e câncer: um enfoque epidemiológico. Rev Nutr 2004; 17 (4): 491-505.
4. Laviano A, Meguid MM, Preziosa I, Fanelli FR. Oxidative stress and wasting in cancer. Curr Opin Clin Nutr Metab Care 2007; 10: 449-456.
5. O'Gorman P, Mcmillan DC, Mcardle CS. Longitudinal study of weight, appetite, performance status and inflammation in advanced gastrointestinal cancer. Nutr Cancer 1999; 35 (2): 127-130.
6. Argiles JM, Alvarez B, Lopez-Soriano FJ. The metabolic basis of cancer cachexia. Med Res Rev 1997; 17 (5): 477-498.
7. Garófolo A, Petrilli AS. Balanço entre ácidos graxos ômega-3 e 6 na resposta inflamatória em pacientes com câncer e caquexia. Rev Nutr Campinas 2006; 19 (5): 611-621.
8. Deans DAC, Tan BH, Wigmore SJ, Ross JA, Beaux AC, Paterson-Brown S, Fearon KCH. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009; 100: 63-69.
9. Mitsuru Ishizuka MD, Hitoshi Nagata MD, Kazutoshi Takagi MD, Toru Horie MD, Keiichi Kubota MD. Inflammation- Based Prognostic Score Is a Novel Predictor of Postoperative Outcome in Patients With Colorectal Cancer. Ann Surg 2007; 246: 1047-1051.
10. McMillan DC, Crozier JE, Canna K et al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007; 22: 881-886.
11. Midha NK, Stratton CW. Laboratory tests in critical care. Crit Care Clin 1998; 14: 15-34.
12. UICC. TNM Classification of Malignant Tumours. 7 ed, 2010.
13. Ottery FD. Definition of standardized nutritional assessment and intervention pathways in oncology. Nutrition 1996; 12 (1): S15-S19.
14. Detsky AS, Mclaughlin JR, Baker JP, Johston N, Whittaker S, Mendelson RA et al. What is subjective global assessment of nutritional states? J Parenter Enteral Nutr 1987; 11: 8-13.
15. Blackburn GL, Bistrian BR. Nutritional and metabolic assessment of the hospitalized patient. JPEN 1977; 1: 11-22.
16. World Health Organization. Physical status: the use and interpretation of anthropometry. Genebra, 1995.
17. World Health Organization. Anales da 36a Reunión del Comité Asesor de Investigaciones en salud. Encuesta multicentrica: salud, bien estar y envejecimiento (SABE) en América Latina y el Caribe. Washington, 2001.
18. Sacher RA, Mcpherson RA. Widmann. Interpretação clínica dos exames laboratoriais. São Paulo: Manole, 2002.
19. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2006; 29 (1): S43-S48.
20. Holanda LB, Barros Filho AA. Métodos aplicados em inquéritos alimentares. Rev Paul Pediatria 2006; 24 (1): 62-70.
21. Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Consenso Nacional de Nutrição Oncológica. Instituto Nacional de Câncer. Rio de Janeiro: INCA, 2009.
22. Forrest LM, Mcmillan DC, Mcardle CS et al. A prospective longitudinal study of performance status, an inflammationbased score (GPS) and survival in patients with inoperable nonsmall-cell lung cancer. Br J Cancer 2005; 92: 1834-1836.
23. Elahi MM, McMillan DC, McArdle CS et al. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer 2004; 48: 171-173.
24. Brown DJ, Milroy R, Preston R et al. The relationship between an inflammation based prognostic score (GPS) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol 2007; 60: 705-708.
25. Lima JCC, Moreira A, Lima D, Correia LCL. Validação da medida de proteína C-reativa (PCR-as) por quimioluminescência para estimativa de risco cardiovascular em indivíduos ambulatoriais: análise comparativa com nefelometria. J Bras Patol Med Lab 2005; 41 (1): 15-19.
26. Correia CR, Angeli AYO, Camargo NR et al. Comparação entre a relação PCR/Albumina e o índice prognóstico inflamatório nutricional (IPIN). J Bras Patol Med Lab 2002; 38 (3): 183-190.
27. Bozzetti F, Forbes A. The ESPEN clinical practice guidelines on Parenteral Nutrition: Present status and perspectives for future research. Clin Nutr 2009; 28 (4): 359-364.
28. Proctor MJ, Talwar D, Balmar SM, O'Reilly DSJ, Foulis AK, Horgan PG, Morrison DS, McMillan DC. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer 2010; 103: 870-876.
29. Ulsenheimer A, Silva ACP, Fortuna FV. Perfil nutricional de pacientes com câncer segundo diferentes indicadores de avaliação. Rev Bras Nutr Clin 2007; 22 (4): 292-297.
30. Moreira RC, Jardim VA, Ramos BP, Portela MC, Marques RG, Diestel CF. Relação entre o estadiamento do câncer colorretal e o estado nutricional na internação hospitalar em pacientes submetidos a procedimentos cirúrgicos. Rev Bras Nutr Clin 2009; 24 (4): 211-216.
31. Wu BW, Yin T, Cao WX, Gu ZD, Wang XJ, Yan M, Liu BY. Clinical application of subjective global assessment in Chinese patients with gastrointestinal cancer. World J Gastroenterol 2009; 15 (28): 3542-3549.
32. Maio R, Berto JC, Côrrea CR, Campana AO, Paiva SAR. Estado nutricional e atividade inflamatória no pré-operatório em pacientes com cânceres da cavidade oral e da orofaringe. Rev Bras Cancerol 2009; 55 (4): 345-353.
33. Crozier JE, McMillan DC, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McKee RF. Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer. J Gastroenterol Hepatol 2007; 22 (12): 2288-2291.
34. August DA, Maureen B, Huhmann, DCN, American Society for Parenteral and Enteral Nutrition (ASPEN). Clinical Guidelines: Nutrition Support Therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parenter Enteral Nutr 2009; 33: 472-500.
35. Roxburgh CSD, Salmond JM, Horgan PG, Oien KA, McMillan DC. Comparison of the prognostic value of inflammationbased pathologic and biochemical criteria in patients undergoing potencially curative resection for colorectal cancer. Ann Surg 2009; 249: 788-793.